⌘K

Login Start Free

Home/Filings/4/0000899243-22-034121

4//SEC Filing

BB BIOTECH AG 4

Accession 0000899243-22-034121

CIK 0001701541other

View on SEC.gov Company Profile

Filed

Oct 24, 8:00 PM ET

Accepted

Oct 25, 4:24 PM ET

Size

6.4 KB

Accession

0000899243-22-034121

Insider Transaction Report

Form 4

Period: 2022-10-21

Black Diamond Therapeutics, Inc.BDTX

10% Owner

Transactions

Purchase
Common Stock
2022-10-21$1.51/sh+87,850$132,750→ 4,913,386 total

BIOTECH GROWTH N V

10% Owner

Transactions

Purchase
Common Stock
2022-10-21$1.51/sh+87,850$132,750→ 4,913,386 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Black Diamond Therapeutics, Inc.

CIK 0001701541

Entity typeother

IncorporatedSwitzerland

Related Parties

1

filerCIK 0000924223

Filing Metadata

Form type: 4
Filed: Oct 24, 8:00 PM ET
Accepted: Oct 25, 4:24 PM ET
Size: 6.4 KB

View on SEC.gov